Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Barker

Showing results (281-290 of 293) with videos related to

Pageof 30
Sort By:
Alzheimer Disease and Associated Disorders|December 7, 2002
Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain BankWarren W Barker, Cheryl A Luis, Alice Kashuba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III MelanomaRobyn D Gartrell, Douglas K Marks, Emanuelle M Rizk, et al.
Cancer Research|January 18, 2020
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary MelanomaRobyn D Gartrell-Corrado, Andrew X Chen, Emanuelle M Rizk, et al.
Journal of Tissue Engineering|November 11, 2014
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot studyBenjamin M Davies, Sarah Rikabi, Anna French, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217Breton M Asken, Rosie E Curiel Cid, Elizabeth A Crocco, et al.
Cardiovascular Research|October 1, 2025
RRAD-reduction reveals efficacy of targeting L-type calcium channel regulation for treatment of heart failureGarrett Elmore, Sarisha S Lohano, Nicholas M McVay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2023
Plasma Alzheimer's biomarkers and brain amyloid in Hispanic and non-Hispanic older adultsBreton M Asken, Wei-En Wang, Karen McFarland, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 19, 2026
Factors associated with discordant visual and quantitative amyloid PET resultsJasmin E Guevara, Emily F Matusz, Wei-En Wang, et al.
Stem Cells Translational Medicine|February 5, 2015
Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standardsAnna French, Christopher Bravery, James Smith, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 18, 2024
Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adultsBreton M Asken, Jesse C DeSimone, Wei-En Wang, et al.
Pageof 30

Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
Alzheimer Disease and Associated Disorders|December 7, 2002
Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain BankWarren W Barker, Cheryl A Luis, Alice Kashuba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III MelanomaRobyn D Gartrell, Douglas K Marks, Emanuelle M Rizk, et al.
Cancer Research|January 18, 2020
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary MelanomaRobyn D Gartrell-Corrado, Andrew X Chen, Emanuelle M Rizk, et al.
Journal of Tissue Engineering|November 11, 2014
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot studyBenjamin M Davies, Sarah Rikabi, Anna French, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217Breton M Asken, Rosie E Curiel Cid, Elizabeth A Crocco, et al.
Cardiovascular Research|October 1, 2025
RRAD-reduction reveals efficacy of targeting L-type calcium channel regulation for treatment of heart failureGarrett Elmore, Sarisha S Lohano, Nicholas M McVay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2023
Plasma Alzheimer's biomarkers and brain amyloid in Hispanic and non-Hispanic older adultsBreton M Asken, Wei-En Wang, Karen McFarland, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 19, 2026
Factors associated with discordant visual and quantitative amyloid PET resultsJasmin E Guevara, Emily F Matusz, Wei-En Wang, et al.
Stem Cells Translational Medicine|February 5, 2015
Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standardsAnna French, Christopher Bravery, James Smith, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 18, 2024
Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adultsBreton M Asken, Jesse C DeSimone, Wei-En Wang, et al.
Pageof 30